GLISITAPTIN M 50/500
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition sitagliptin phosphate 50 mg and metformin hydrochloride 500 mg
Rs 127.97
MRP Rs 182.81
(30% OFF)
Includes all taxes
Package SIZE
( For 15 TABS )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
GLISITAPTIN M 50/500 is a fixed-dose combination medicine used in the management of Type 2 Diabetes Mellitus, bringing together two well-established, complementary anti-diabetic agents that address blood sugar control through distinct pathways.
Sitagliptin Phosphate, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor, works by preserving the activity of incretin hormones in the body. These hormones help the pancreas release insulin more effectively in response to food intake, while also helping to reduce excess glucose production by the liver. Because its action is closely tied to meal-related glucose rises rather than working continuously, Sitagliptin carries a relatively low intrinsic risk of causing hypoglycemia on its own.
Metformin Hydrochloride, a biguanide, works through a different mechanism — reducing the amount of glucose the liver releases into the bloodstream and improving the sensitivity of body tissues to insulin, allowing existing insulin to work more efficiently.
By combining a medicine that enhances the body's own meal-time insulin response (Sitagliptin) with one that reduces glucose production and improves insulin sensitivity (Metformin), GLISITAPTIN M 50/500 addresses blood sugar control from two complementary angles. This combination is often well-suited for patients who need improved glycemic control while wanting to minimize the risk of low blood sugar episodes, which can be a particular concern with older sulfonylurea-based combinations.
Product Information
| Attribute | Details |
|---|---|
| Brand Name | GLISITAPTIN M 50/500 |
| Composition | Sitagliptin Phosphate 50 mg + Metformin Hydrochloride 500 mg |
| Therapeutic Class | Anti-diabetic — DPP-4 Inhibitor + Biguanide (Fixed-Dose Combination) |
| Manufacturer/Marketer | Steris Healthcare Pvt. Ltd. |
| Product Form | Tablet |
| Pack Size | 15 Tablets |
| Prescription Status | Schedule H — Prescription drug only |
| Price (MRP) | ₹[Placeholder — insert price] |
| SKU / Batch Ref. | [Placeholder — insert SKU] |
| Storage | Store below 25°C, in a cool, dry place, protected from light and moisture |
Why GLISITAPTIN M 50/500 Is Important
Type 2 diabetes is a progressive condition, and for many patients, blood sugar control with Metformin alone becomes insufficient over time. At the same time, not all patients are ideal candidates for combinations that carry a higher hypoglycemia risk — particularly elderly patients, those living alone, or those with irregular meal patterns. GLISITAPTIN M 50/500 addresses this gap by offering effective glycemic control with a gentler side-effect profile in this regard.
GLISITAPTIN M 50/500 is clinically important because it:
- Offers dual-mechanism blood sugar control, combining enhanced meal-time insulin response with improved insulin sensitivity
- The low intrinsic hypoglycemia risk of Sitagliptin makes it a comfortable option for patients concerned about frequent low blood sugar episodes, including the elderly
- Provides a practical treatment intensification option for patients whose diabetes is not adequately controlled on Metformin alone
- Simplifies treatment by combining two medicines into one tablet, reducing pill burden and supporting better adherence
- Supports better long-term HbA1c control, directly linked to reduced risk of diabetes-related complications
- Offers a well-established, extensively used combination backed by long clinical experience in diabetes management
Because this combination involves two distinct drug classes, it still requires careful physician oversight, particularly around kidney function monitoring for the Metformin component.
Key Benefits
- Dual-mechanism action — combines enhanced insulin response with improved insulin sensitivity for effective blood sugar control
- Low intrinsic hypoglycemia risk from the Sitagliptin component, making it suitable for a wider range of patients, including the elderly
- Reduces pill burden by combining two anti-diabetic medicines into a single tablet
- Supports better long-term HbA1c and glycemic control, reducing risk of diabetes-related complications
- Useful intensification option for patients not adequately controlled on Metformin alone
- Well-established combination with a long track record of clinical use in Type 2 diabetes management
- Backed by WHO-GMP certified manufacturing, ensuring consistent tablet quality and dosing accuracy
Precautions
- Should be used only under medical supervision, with regular monitoring of blood glucose, HbA1c, and kidney function
- Caution advised in patients with kidney impairment, as Metformin use requires dose adjustment or avoidance based on kidney function levels
- Should be used cautiously in patients with liver disease, heart failure, or conditions predisposing to lactic acidosis (a rare but serious risk associated with Metformin)
- Alcohol should be avoided or limited, as it can increase the risk of lactic acidosis
- Temporary discontinuation may be required before procedures involving contrast dye (imaging scans) or major surgery — inform all treating doctors that this medicine is being taken
- Rare reports of pancreatitis have been associated with DPP-4 inhibitors like Sitagliptin — persistent abdominal pain should be reported to a doctor promptly
- Not recommended during pregnancy or breastfeeding unless specifically advised by a physician
- Elderly patients should still be monitored for overall tolerability, even though hypoglycemia risk is lower with this combination
- Inform the doctor of all other medications, as several drug classes can interact with components of this combination
Side Effects
- Gastrointestinal discomfort — nausea, bloating, or diarrhea (particularly with the Metformin component, often improving over time)
- Headache
- Nasopharyngitis (common cold-like symptoms, occasionally reported with Sitagliptin)
- Metallic taste in the mouth
- Loss of appetite
- Mild hypoglycemia risk, lower than with sulfonylurea-based combinations but still possible, especially if combined with other blood-sugar-lowering agents
- Rarely: lactic acidosis (a serious condition requiring emergency care)
- Rarely: pancreatitis (persistent, severe abdominal pain should be reported immediately)
- Rarely: allergic skin reactions
Frequently Asked Questions
1. Where can I buy Sitagliptin Phosphate and Metformin Hydrochloride Tablets online?
Sitagliptin Phosphate and Metformin Hydrochloride Tablets can be purchased online through licensed pharmacies and authorized pharmaceutical suppliers in India. Always verify the product, manufacturer, packaging, and prescription requirements before placing an order.
2. What is the price of Sitagliptin Phosphate and Metformin Hydrochloride Tablets?
The price depends on the strength, brand, pack size, manufacturer, and applicable offers. Check the current product listing or contact the authorized seller for the latest price before ordering.
3. Can I order Sitagliptin Phosphate and Metformin Hydrochloride Tablets online?
Yes, these tablets may be ordered online from licensed pharmacies or authorized sellers, subject to availability and applicable prescription requirements. Use a trusted source and check the product details before purchase.
4. Is Sitagliptin Phosphate and Metformin Hydrochloride Tablets available from Steris Healthcare?
Availability from Steris Healthcare depends on the specific brand, strength, and current stock. You can check the relevant Steris Healthcare product listing or contact the company directly to confirm availability, pricing, and ordering details.
5. What is Sitagliptin Phosphate and Metformin Hydrochloride Tablets used for?
Sitagliptin Phosphate and Metformin Hydrochloride Tablets are prescription medicines used along with diet and exercise to help control blood glucose levels in adults with type 2 diabetes mellitus. They combine two medicines with different mechanisms for improving blood sugar control.
6. What is the composition of Sitagliptin Phosphate and Metformin Hydrochloride Tablets?
The tablets contain Sitagliptin Phosphate and Metformin Hydrochloride as active ingredients. The exact quantity of each ingredient depends on the prescribed strength, so check the product packaging or prescription for the specific composition.
7. Is a prescription required for Sitagliptin Phosphate and Metformin Hydrochloride Tablets?
Yes. These are prescription medicines and should be used under the guidance of a qualified healthcare professional. Do not start, stop, or change the dose without medical advice.
8. How should Sitagliptin Phosphate and Metformin Hydrochloride Tablets be taken?
Take the tablets exactly as prescribed by your doctor. They are generally taken with meals to help reduce stomach-related side effects from metformin. Swallow the tablet as directed and do not alter the prescribed dose without consulting your healthcare professional.
9. What should I know before buying Sitagliptin Phosphate and Metformin Hydrochloride Tablets?
Before buying, verify the brand name, strength, composition, manufacturer, pack size, batch number, expiry date, and prescription requirements. Inform your doctor about existing medical conditions and other medicines you take, particularly if you have kidney or liver problems.
10. How can I order Sitagliptin Phosphate and Metformin Hydrochloride Tablets online?
To order online, select the required brand and strength from a licensed pharmacy or authorized supplier, verify the product and prescription requirements, and complete the order using the available payment and delivery options. Always purchase medicines from a reliable source and check the packaging when the product arrives.